Cyclosporine neurotoxicity: a review

[1]  S. Bohlega,et al.  Neurological complications in liver transplantation , 2001, Journal of Neurology.

[2]  S. Snyder,et al.  Neural actions of immunophilin ligands. , 1998, Trends in pharmacological sciences.

[3]  D. Andrews,et al.  Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. , 1997, Journal of computer assisted tomography.

[4]  Joshua Miller,et al.  A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1 , 1997 .

[5]  R. Wiesner,et al.  Causes and outcome of seizures in liver transplant recipients , 1996, Neurology.

[6]  E. Wijdicks,et al.  Treatment-refractory cyclosporine-associated headache , 1996, Neurology.

[7]  J. Mcdonald,et al.  Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures , 1996, Annals of neurology.

[8]  S. Small,et al.  Immunosuppression‐induced leukoencephalopathy from tacrolimus (FK506) , 1996, Annals of neurology.

[9]  L R Caplan,et al.  A reversible posterior leukoencephalopathy syndrome. , 1996, The New England journal of medicine.

[10]  H. Trivedi,et al.  Hypocholesterolemia is not associated with neurotoxicity in renal transplant patients. , 1996, The International journal of artificial organs.

[11]  E. Tolosa,et al.  Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia , 1996, Neurology.

[12]  D. Pelz,et al.  Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation. , 1996, Transplantation.

[13]  D. Krieger,et al.  Cortical hyperintensity on proton density-weighted images: An MR sign of cyclosporine-related encephalopathy. , 1996, AJNR. American journal of neuroradiology.

[14]  E. Tolosa,et al.  Cyclosporine-associated mutism in liver transplant patients , 1996, Neurology.

[15]  R. Wiesner,et al.  Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression , 1995, Neurology.

[16]  H. Greinix,et al.  MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT‐VERSUS-HOST DISEASE PROPHYLAXIS , 1995, Transplantation.

[17]  P. Barnes,et al.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. , 1995, AJR. American journal of roentgenology.

[18]  K. Leveno,et al.  A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. , 1995, The New England journal of medicine.

[19]  A. Grünert,et al.  Elevated plasma endothelin concentrations in cyclosporine-treated patients after bone marrow transplantation. , 1995, Bone marrow transplantation.

[20]  E. Nussbaum,et al.  Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. Case report. , 1995, Journal of neurosurgery.

[21]  W. Bechstein,et al.  Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation. , 1995, Clinical transplantation.

[22]  Charles M. Miller,et al.  FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation: Results from the U.S. multicenter trial , 1995 .

[23]  J. Nemunaitis,et al.  Bone marrow transplant-associated thrombotic microangiopathy: a case series. , 1995, Bone marrow transplantation.

[24]  R. Busuttil,et al.  FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. , 1995, Transplantation.

[25]  W. Bechstein,et al.  Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506‐treated patients , 1994, Transplant international : official journal of the European Society for Organ Transplantation.

[26]  R. Patchell.  Neurological complications of organ transplantation , 1994, Annals of neurology.

[27]  A. Pettitt,et al.  Thrombotic microangiopathy following bone marrow transplantation. , 1994, Bone marrow transplantation.

[28]  A. Burroughs,et al.  Cyclosporin associated headache. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[29]  W. Bechstein,et al.  Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. , 1994, Transplantation.

[30]  E. Tolosa,et al.  Predictive factors of in‐hospital CNS complications following liver transplantation , 1994, Neurology.

[31]  S. McCann,et al.  Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine. , 1994, Bone marrow transplantation.

[32]  J. Leyden,et al.  Acute reversible central nervous system toxicity associated with low-dose oral cyclosporine therapy. , 1993, Journal of the American Academy of Dermatology.

[33]  R. N. Garrison,et al.  Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1. , 1993, Surgery.

[34]  L. Carlis,et al.  Dysarthria and cerebellar ataxia: late occurrence of severe neurotoxicity in a liver transplant recipient , 1993, Transplant international : official journal of the European Society for Organ Transplantation.

[35]  N. Rocha,et al.  Cyclosporin A-induced neurotoxicity , 1993 .

[36]  T. Nozue,et al.  EVIDENCE THAT CYCLOSPORINE CAUSES BOTH INTRACELLULAR MIGRATION AND INAPPROPRIATE URINARY EXCRETION OF MAGNESIUM IN RATS1 , 1993, Transplantation.

[37]  N. Rocha,et al.  Case report: cyclosporin A-induced neurotoxicity. , 1993, The British journal of radiology.

[38]  J. Bowler,et al.  Delusions and cyclosporine toxicity. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[39]  W. Carey,et al.  Neurological complications following liver transplantation , 1992, Annals of neurology.

[40]  A. Gratwohl,et al.  Microvasculopathy in the ocular fundus after bone marrow transplantation. , 1991, Annals of internal medicine.

[41]  R. Gascoyne,et al.  Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. , 1991, Bone marrow transplantation.

[42]  D. Jabs,et al.  Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity. , 1991, Ophthalmology.

[43]  R. McGhee,et al.  Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy. , 1991, Transplantation.

[44]  R. Toto,et al.  Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  R. Steg,et al.  Complex visual hallucinations and cyclosporine neurotoxicity , 1991, Neurology.

[46]  C. Truwit,et al.  MR imaging of reversible cyclosporin A-induced neurotoxicity. , 1991, AJNR. American journal of neuroradiology.

[47]  C. Szabó,et al.  Contractile and Endothelium-Dependent Dilatory Responses of Cerebral Arteries at Various Extracellular Magnesium Concentrations , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  F. Gottrand,et al.  Cyclosporine neurotoxicity. , 1991, The New England journal of medicine.

[49]  R. Williams,et al.  Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[50]  J. A. Vázquez de Prada,et al.  Cyclosporine neurotoxicity in heart transplantation. , 1990, The Journal of heart transplantation.

[51]  R. L. Hughes.  Cyclosporine-related central nervous system toxicity in cardiac transplantation. , 1990, The New England journal of medicine.

[52]  R. Ghalie,et al.  Cortical blindness: a rare complication of cyclosporine therapy. , 1990, Bone marrow transplantation.

[53]  R. Hutchinson,et al.  Migraine after bone-marrow transplantation , 1990, The Lancet.

[54]  P. Wong,et al.  Complex partial status epilepticus associated with cyclosporin A therapy. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[55]  P. C. Groen.  Cyclosporine: a review and its specific use in liver transplantation. , 1989, Mayo Clinic proceedings.

[56]  J. Chang,et al.  Cyclosporin associated demyelination following allogeneic bone marrow transplantation , 1989, Hematological oncology.

[57]  L. Lange,et al.  Cyclosporin neurotoxicity in cardiac transplant recipients. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[58]  P. C. Groen.  Cyclosporine, low-density lipoprotein, and cholesterol. , 1988 .

[59]  W. Carey,et al.  NEUROLOGIC COMPLICATIONS OF LIVER TRANSPLANTATION , 1988, Transplantation.

[60]  J. Brochstein,et al.  Neurologic complications of immunosuppressive agents. , 1988, Neurologic clinics.

[61]  R. Krom,et al.  Cyclosporine-associated central nervous system toxicity. , 1988, The New England journal of medicine.

[62]  H. Sollinger,et al.  Cyclosporine neurotoxicity in liver transplant recipients: report of three cases. , 1988, Transplantation proceedings.

[63]  R. Wiesner,et al.  Cyclosporin A-induced reversible cortical blindness. , 1988, Journal of clinical neuro-ophthalmology.

[64]  P. de Groen.  Cyclosporine, low-density lipoprotein, and cholesterol. , 1988, Mayo Clinic proceedings.

[65]  G. Forbes,et al.  Central Nervous System Toxicity after Liver Transplantation , 1987 .

[66]  Alan M. Rubin,et al.  Cerebral blindness and encephalopathy with cyclosporin A toxicity , 1987, Neurology.

[67]  D. Adams,et al.  NEUROLOGICAL COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION , 1987, The Lancet.

[68]  G. Forbes,et al.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. , 1987, The New England journal of medicine.

[69]  D. O'Sullivan.  Convulsions associated with cyclosporin A. , 1985, British medical journal.

[70]  A. Keyser,et al.  SEVERE CENTRAL-NERVOUS-SYSTEM TOXICITY ASSOCIATED WITH CYCLOSPORIN , 1985, The Lancet.

[71]  J. Walls,et al.  Convulsions associated with cyclosporin A in renal transplant recipients. , 1985, British medical journal.

[72]  K. Sullivan,et al.  ASSOCIATION BETWEEN CYCLOSPORIN NEUROTOXICITY AND HYPOMAGNESAEMIA , 1984, The Lancet.

[73]  R. Noll,et al.  Complex visual hallucinations and cyclosporine. , 1984, Archives of neurology.

[74]  E. Gordon-Smith,et al.  CYCLOSPORIN A, METHYLPREDNISOLONE, AND CONVULSIONS , 1982, The Lancet.

[75]  A. Barrett,et al.  HYPERTENSION AND CONVULSIONS IN CHILDREN RECEIVING CYCLOSPORIN A , 1982, The Lancet.